Bilateral Synchronous Breast Cancer and HER-2/neu Overexpression

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

Irene L. Andrulis, Shelley B. Bull, Martin E. Blackstein et al. · Journal of Clinical Oncology · 1998 · 447 citations

Medicine, Oncology, Pathology +16

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.

Chiara Carlomagno, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 1996 · 409 citations

Medicine, Oncology, Breast Oncology +13

HER-2/neu (c-erb-B2) gene and protein in breast cancer.

Jeffrey S. Ross, Jonathan A. Fletcher · PubMed · 1999 · 272 citations

Medicine, Molecular Biology, Oncology +17

Bilateral primary breast cancer: A prospective study of disease incidence

M.A. Chaudary, Rosemary R. Millis, E. O. L. Hoskins et al. · British journal of surgery · 1984 · 245 citations

Medicine, Oncology, Radiology +14

Risk Factors Predicting the Incidence of Second Primary Breast Cancer among Women Diagnosed with a First Primary Breast Cancer*

Jonine L. Bernstein, W. Douglas Thompson, Neil Risch et al. · American Journal of Epidemiology · 1992 · 161 citations

Medicine, Oncology, Cancer Epidemiology +13